Introducing EksoNR - the most versatile exoskeleton therapy solution in the market. With its unique features and benefits over 480 rehabilitation centers worldwide have implemented EksoNR to aid in their patients' recovery journey.
- Widest Patient Population: Rehabilitation centers using EksoNR are able to offer exoskeleton therapy to the widest patient population among all mobile exoskeletons on the market.
- FDA-Cleared: EksoNR is the first FDA-cleared robotic exoskeleton for Spinal Cord Injury (level C7 to L5), Stroke, Acquired Brain Injury (ABI), and Multiple Sclerosis.
- Versatile: From early mobilization to outpatient use, EksoNR supports side and backwards stepping and is a 3-in-1 training device for gait, balance, and standing.
- Research-Backed: With over 180 studies and publications, EksoNR is the most researched mobile exoskeleton on the market.
- Natural Gait: EksoNR promotes the industry's most natural gait, helping patients to move with confidence and ease.
- Proven Results: With over 35,000 patients taking over 200 million steps, EksoNR has proven to be an effective therapy solution for patients of varying conditions and stages of recovery.
- SmartAssist™ Software: The software tailors the treatment session to the specific patients' needs, allowing for use in all phases of rehabilitation from early balance and weight-shifting exercises to a trajectory free walking mode for both legs with added resistance.
- FES integration: EksoNR can be combined with Functional Electrical Stimulation (FES)